It is more than obvious SPL7013 is a rather versatile molecule
It wouldn't surprise me if Starpharma have and are talking with big pharma in a joint collaboration to further develop SPL7013 for other indications
If you browse the latest newsletter this comment has been conveyed
Versatility of SPL7013 molecule
Add SPL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
9.8¢ |
Change
-0.002(2.00%) |
Mkt cap ! $40.48M | |||
| Open | High | Low | Value | Volume |
| 10.0¢ | 10.0¢ | 9.7¢ | $37.67K | 384.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 100000 | 9.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 9.8¢ | 39723 | 3 |
View Market Depth
| Last trade - 12.35pm 03/10/2024 (20 minute delay) ? |
| SPL (ASX) Chart |